Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | DNM1 | Q05193 | 9/20 | 0.88 |
| ▸ | CA12 | O43570 | 3/20 | 0.88 |
| ▸ | CA1 | P00915 | 3/20 | 0.88 |
| ▸ | CA2 | P00918 | 3/20 | 0.88 |
| ▸ | CA3 | P07451 | 3/20 | 0.88 |
| ▸ | CA4 | P22748 | 3/20 | 0.88 |
| ▸ | CA6 | P23280 | 3/20 | 0.88 |
| ▸ | CA5A | P35218 | 3/20 | 0.88 |
| ▸ | CA7 | P43166 | 3/20 | 0.88 |
| ▸ | CA9 | Q16790 | 3/20 | 0.88 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.88 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.88 |
| ▸ | TSHR | P16473 | 3/20 | 0.88 |
| ▸ | LMNA | P02545 | 1/20 | 0.88 |
| ▸ | BLM | P54132 | 1/20 | 0.88 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Putrescine SCHEMBL21642 | 1.00 | — | — | |
| Putrescine SCHEMBL22227753 | 0.94 | — | — | |
| SCHEMBL7189680 | 0.94 | DNM1 (1.00) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL887774 | 0.94 | DNM1 (1.00) | NFKB1DNM1CA12CA1CA2 | |
| Diaminooctane SCHEMBL8650707 | 0.94 | DNM1 (1.00) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL25262966 | 0.94 | DNM1 (1.00) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL22684930 | 0.94 | DNM1 (1.00) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL22684932 | 0.94 | DNM1 (1.00) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL22283336 | 0.94 | DNM1 (1.00) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL16390420 | 0.94 | DNM1 (1.00) | NFKB1DNM1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113834927-A | Salivary metabolism marker for predicting canceration of oral mucosa precancerous lesion patient and application thereof | 南京市口腔医院 | 2021-12-24 | — | — | CN | claimed |
| CN-106635953-B | Serum-free and protein-free cell culture medium | 昆明润什生物科技有限公司 | 2021-02-19 | — | — | CN | claimed |
| CN-105969723-A | Method for efficiently separating mouse spermatogonial stem cells | 内蒙古大学 | 2016-09-28 | — | — | CN | claimed |
| US-5646236-A | POLYAMINE REACTANT; METAL ELECTRODEPOSITION BATHS | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-07-08 | — | — | US | claimed |
| US-12480131-B2 | Tropane alkaloid (TA) producing non-plant host cells, and methods of making and using the same | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-11-25 | — | — | US | disclosed |
| EP-4591872-A1 | COMPOSITION COMPRISING LACTOBACILLUS PLANTARUM STRAIN FOR IMPROVING INTESTINAL METABOLITE COMPOSITION | Gi Biome Inc. (KR) | 2025-07-30 | — | — | EP | disclosed |
| CN-120152723-A | Composition for improving intestinal metabolite composition comprising lactobacillus plantarum strain | GI生物群系公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-113784758-B | Non-plant host cells producing tropane alkaloids (TA) and methods of making and using the same | 小利兰·斯坦福大学托管委员会 | 2025-03-07 | — | — | CN | disclosed |
| US-12215394-B2 | Molecular marker nicotine associated SNP 1 for identifying high or low nicotine content of tobacco and its kit as well as use thereof | YUNNAN ACADEMY OF TOBACCO AGRICULTURAL SCIENCES (CN) | 2025-02-04 | — | — | US | disclosed |
| CN-118436656-A | Application of evodiamine in regulating polyamine metabolism, YAP protein phosphorylation and nuclear translocation in colorectal cancer | 重庆医科大学 | 2024-08-06 | — | — | CN | disclosed |
| US-20240191267-A1 | Tropane Alkaloid Transporters and Methods of Making Tropane Alkaloids Using the Same | HERCULES CAPITAL, INC., AS AGENT | 2024-06-13 | — | — | US | disclosed |
| WO-2024058984-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2024-03-21 | — | — | WO | disclosed |
| US-20070259332-A1 | Compositions and methods for simultaneous detection of volatile sulfur compounds and polyamines | PDX BIOTECH LLC | 2007-11-08 | — | — | US | disclosed |
| US-7196124-B2 | Elastomeric material compositions obtained from castor oil and epoxidized soybean oil | TEXAS TECH UNIVERSITY (US) | 2007-03-27 | — | — | US | disclosed |
| US-20040235962-A1 | Conformationally restricted polyamine analogs as disease therapies | CELLGATE, INC. | 2004-11-25 | — | — | US | disclosed |
| EP-1075254-A2 | THE USE OF POLYAMINES IN THE TREATMENT OF DERMATOLOGICAL SYMPTOMS | Ilenchuk, Theodore Toney (CA) | 2001-02-14 | — | — | EP | disclosed |
| WO-1999051213-A2 | THE USE OF POLYAMINES IN THE TREATMENT OF DERMATOLOGICAL SYMPTOMS | ILENCHUK THEODORE TONEY (CA) | 1999-10-14 | — | — | WO | disclosed |
| EP-0522758-B1 | Surface-roughened film and method for fabricating thereof | UNITIKA LTD (JP) | 1998-05-27 | — | — | EP | disclosed |
| US-5354595-A | Contains a thermoplastic resin, such as amorphous nylon, having glass transition temperature 10 degrees higher than that of polyester resin; critical surface tension; melt viscosity; shear rate | UNITIKA, LTD. (JP) | 1994-10-11 | — | — | US | disclosed |
| EP-0522758-A1 | Surface-roughened film and method for fabricating thereof | UNITIKA LTD. (JP) | 1993-01-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235962-A1 | Conformationally restricted polyamine analogs as disease therapies | SRM, PYCR1, PAICS | NFKB1 3815/4885DNM1 739/4885CA12 3283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.